09/30/2022
4:32 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
09/29/2022
4:15 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2022
6:39 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2022
7:08 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2022
6:11 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2022
4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2022
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2022
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/05/2022
1:26 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2022
6:31 AM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/14/2021
4:25 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2021
3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2021
5:59 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2021
5:44 PM | Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2021
3:47 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2021
3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2021
4:15 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2021
5:51 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
4:56 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
9:30 AM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/04/2021
3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/04/2021
3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2021
8:54 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/19/2021
4:58 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2021
4:49 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2021
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2021
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
5:11 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
5:08 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
5:02 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:27 PM | Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:24 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:22 PM | Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:20 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:16 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:14 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:11 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:07 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:01 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
5:02 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2020
4:52 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2020
4:55 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
4:55 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
5:26 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2020
5:16 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
6:07 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
4:58 PM | Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
3:34 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/20/2020
5:03 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2020
4:49 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/02/2020
5:11 PM | Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/26/2020
5:02 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2020
6:35 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2020
5:02 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2020
5:01 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2020
4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2020
5:31 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/08/2020
6:35 AM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2020
5:08 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
4:14 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
06/26/2020
5:02 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
5:10 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
5:27 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2020
5:48 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2020
5:45 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2020
6:19 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2020
6:00 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2020
6:47 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2020
4:18 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
1:47 PM | Arrowhead Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
| Form SC 13G/A
| |
01/28/2020
3:31 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/23/2020
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form PRE 14A
| |
01/13/2020
4:13 PM | Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2020
5:35 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:33 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:31 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:10 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:08 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2020
5:02 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
3:54 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
3:51 PM | Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2019
5:35 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2019
8:55 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/04/2019
5:48 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2019
3:48 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/02/2019
3:02 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-3ASR
| |
11/25/2019
3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/25/2019
3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2019
5:48 PM | Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2019
5:44 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2019
5:45 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2019
6:32 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2019
6:31 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2019
9:56 AM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
09/27/2019
8:16 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2019
8:12 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
7:09 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
